The current PE ratio for Abbott Laboratories stock as of Apr 26, 2024 is 32.78. This is calculated based on the current EPS of $3.28 and the stock price of $107.53 per share. The P/E ratio has a decrease of 2.1% from the past four quarters average of 33.5.
The average historical PE ratio of Abbott Laboratories for the last ten years is 50.18. The current PE ratio of 32.78 is 35% below the historical average. Over the past ten years, ABT's PE ratio was at its highest in the Mar 2018 quarter at 230.46, when the stock price was $59.92 and the EPS was $0.26. The lowest value was in the Sep 2015 quarter, when it reached 13.27 with a price of $40.22 and an EPS of $3.03.
Maximum annual increase: 417.3% in 2017
Maximum annual decrease: -74.46% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 33.56 | 20.42% |
| 2022 | 27.87 | -21.38% |
| 2021 | 35.45 | -18.41% |
| 2020 | 43.45 | 3.55% |
| 2019 | 41.96 | -22.27% |
| 2018 | 53.98 | -74.46% |
| 2017 | 211.37 | 417.3% |
| 2016 | 40.86 | 167.41% |
| 2015 | 15.28 | -49.08% |
| 2014 | 30.01 | 28.41% |
ABT's current P/E ratio is above the 3-year historical average, but it is below the 5 and 10-year averages.
Compared to its peers AZN and TMO, ABT's PE ratio stands lower, however it is higher than JNJ's and NVS's. Abbott Laboratories's PE ratio is trading below the peer group average of 36.63.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.53 | $352.02B |
| NVS Novartis AG | 13.15 | $198.82B |
| MDT Medtronic plc | 25.31 | $105.88B |
| ABT Abbott Laboratories | 32.78 | $186.58B |
| HOLX Hologic Inc | 35.84 | $17.83B |
| AZN Astrazeneca plc | 36.67 | $233.05B |
| TMO Thermo Fisher Scientific Inc | 36.96 | $218.72B |
| PFE Pfizer Inc | 66.84 | $143.43B |
| BSX Boston Scientific Corp | 67.75 | $107.35B |
| BMY Bristol Myers Squibb Co | N/A | $90.92B |
As of Apr 26, 2024, ABT stock has a price to earnings ratio of 32.78.
The average PE ratio for ABT stock over the past 3 years is 30.02.
The average PE ratio for ABT stock over the past 5 years is 36.73.
Over the last ten years, the quarterly PE ratio reached a historic high of 230.46 in the Mar 2018 quarter.
The current price to earnings ratio of ABT is 35% lower than the 10-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Apr 26, 2024), Abbott Laboratories's stock price is $107.53. The earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $3.28. Therefore, Abbott Laboratories's P/E ratio for today is 32.78. PE RATIO(32.78) = STOCK PRICE($107.53) / TTM EPS($3.28)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.